Invus
New York City, New Yorkinvus.com
Overview
Invus is a global, evergreen equity investment firm founded in 1985 that manages over $10 billion. It partners with entrepreneurs and management teams to transform their industries. The firm's capital originates from a European family group, and it does not raise outside funds, allowing for a long-term investment horizon. Invus invests across various stages, including venture capital, growth/expansion, and private equity buyouts, in sectors such as consumer goods and services, biotech, medical devices, and software.
Portfolio Companies
118
Website
invus.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Soufflé Therapeutics | Oct 2026 | Series B | Co-investor |
| Universal Quantum | Oct 2026 | Series A | Co-investor |
| Matchpoint Therapeutics | Oct 2026 | Series B | Co-investor |
| Precision Neuroscience | Sep 2026 | Series D | Co-investor |
| Caspian Therapeutics, Inc. | Sep 2026 | Series B | Co-investor |
Key People
Julien Miara
Managing Director at Invus
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?